🇺🇸 FDA
Patent

US 7338807

Screening assays for compounds that cause apoptosis

granted A61KA61K38/1709

Quick answer

US patent 7338807 (Screening assays for compounds that cause apoptosis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/1709